Quantcast

Latest insulin pump Stories

2011-03-11 09:00:00

GLEN BURNIE, Md., March 11, 2011 /PRNewswire-USNewswire/ -- In 2010 the APWU Health Plan in a joint venture with UnitedHealthcare introduced an innovative diabetes management program to its Consumer Driven Option members. The program is the first of it's kind in the Federal Employees Health Benefits (FEHB) Program and was an immediate success. The goal of the program is to offer financial incentives to promote good diabetes management. With the APWU Health Plan's Diabetes Management...

2011-03-01 06:30:00

BRIDGEWATER, N.J., March 1, 2011 /PRNewswire/ -- Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that the U.S. Food and Drug Administration has cleared the company's V-Go Disposable Insulin Delivery Device for use with Novo Nordisk's NovoLog® for the continuous subcutaneous delivery of insulin in preset basal rates and with on-demand bolus dosing for adult patients...

2010-12-08 06:30:00

BRIDGEWATER, N.J., Dec. 8, 2010 /PRNewswire/ -- Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that the US Food and Drug Administration has cleared the company's V-Go Disposable Insulin Delivery Device for the continuous subcutaneous delivery of insulin in preset basal rates and with on-demand bolus dosing for adult patients requiring insulin. V-Go devices will be available in a preset...

2010-11-23 03:30:00

DALLAS, November 23, 2010 /PRNewswire/ -- New Report Diabetes Care Device Market in Brazil, Russia, India, and China (BRIC) (2010 - 2014) Published by Marketsandmarkets Market Covered: Insulin pumps, Self monitoring blood glucose, and Continuous glucose monitoring According to the new market research report, "Diabetes care devices market in Brazil, Russia, India, China (BRIC)" ( http://www.marketsandmarkets.com/Market-Reports/diabetes-care-devices-230.htm l) published by...

2010-09-23 08:23:00

DANBURY, Conn., Sept. 23 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) today reported recent findings from the company's diabetes drug research program during a poster session on short-acting insulins at the 46th annual meeting of the European Association for the Study of Diabetes in Stockholm. In the first poster presentation, "Biocompatibility of the ultra-rapid insulin VIAject® (Linjeta(TM)) with continuous insulin infusion sets," Dr. Frank Flacke of Biodel reported that...

2010-09-23 08:00:00

TARRYTOWN, N.Y., Sept. 23 /PRNewswire/ -- According to a new study, people with diabetes, especially those treated with insulin, may achieve optimal blood sugar control when they understand the impact of food on blood sugar and they utilize useful advanced blood glucose meter (BGM) features such as meal markers and audible reminders. These findings, presented at the 46th European Association for the Study of Diabetes (EASD) Annual Meeting in Stockholm, Sweden, are important because...

2010-08-04 14:00:00

INDIANAPOLIS, Aug. 4 /PRNewswire/ -- Roche Diabetes Care, makers of the ACCU-CHEK® portfolio of diabetes management products and services, is pleased to announce the inaugural National Infusion Site Awareness Week, Aug. 30-Sept. 5. Roche made the announcement during the 37th annual American Association of Diabetes Educators (AADE) conference to highlight the important role that certified diabetes educators and other health care professionals play in promoting better site...

2010-07-26 07:30:00

REDWOOD CITY, Calif., July 26 /PRNewswire/ -- Calibra Medical announced today it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Finesse(TM) insulin patch-pen for up to three-day use with Novo Nordisk's Novolog® rapid acting insulin. Combining the mealtime therapy-adherence benefits of insulin pumps with the simplicity and affordability of syringes and pens, Calibra's novel bolus-only patch-pen is a small, adhesively attached, flat...

2010-07-12 06:00:00

DANBURY, Conn., July 12 /PRNewswire-FirstCall/ -- Biodel Inc. (Nasdaq: BIOD) announced today the award of two research grants by the Juvenile Diabetes Research Foundation (www.jdrf.org) to Stanford University and Oregon Health & Science University (OHSU) to evaluate the use of VIAject® (ultra-rapid-acting injectable human insulin) in the treatment of diabetes. The first grant will support clinical testing under the direction of Bruce Buckingham, M.D., professor of...

2010-06-30 12:43:07

Adding a continuous blood sugar level sensor to an insulin pump helps patients with type 1 diabetes achieve better blood sugar control compared to the common standard of care, multiple daily insulin injections, concludes a study published online June 29 in the New England Journal of Medicine. The paper is entitled, Effectiveness of Sensor-Augmented Insulin-Pump therapy in Type 1 Diabetes. "Combining the best technologies for insulin delivery and blood sugar monitoring really pays off for...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.